Forty-two cases of squamous cell carcinoma arising in the upper aerodigestive tract were examined to determine the incidence and type of point mutation in codon 12 of the c-K-ras gene by using the polymerase chain reaction and oligonucleotide hybridization techniques on DNA extracted from paraffin blocks. DNA sequencing, in addition, was performed in 4 cases. No point mutation was detected in codon 12 of c-K-ras in the 42 squamous cell carcinomas we examined. According to the results of DNA sequencing of 4 cases, codon 13 also revealed no point mutation. Thus, point mutational activation of codon 12 of c-k-ras oncogene is an uncommon event in human upper aerodigestive tract squamous cell carcinoma.
SaranathDPanchalRGNairR. Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res1989; 80: 430–7.
2.
BosJL. The ras gene family and human carcinogenesis. Mutat Res1988; 195: 255–71.
3.
AlmogueraCShibataDForresterKMartinJArnheimNPeruchoM. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell1988; 53: 549–54.
4.
HollsteinMCSmitsAMGalianaC. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res1988; 48: 5119–23.
5.
HamataniKNagataYAbeM. Increased expression of ras genes in non-Hodgkin's lymphomas is not associated with oncogenic activation of those genes by point mutation. Jpn J Cancer Res1989; 80: 706–10.
6.
BeahrsOHHensonDEHutterRVPMyersMH, eds. Manual for staging of cancer. 3rd ed.Philadelphia, Pa: JB Lippincott Co, 1988.
7.
GoelzSEHamiltonSRVogelsteinB. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun1985; 130: 118–26.
8.
NeriAKnowlesDMGrecoAMcCormickFDalla-FaveraR. Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA1988; 85: 9268–72.
9.
SaikiRKGelfandDGStoffelS. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science1988; 239: 487–91.
10.
McCabePC. Production of single-stranded DNA by asymmetric PCR. In: InnisMAGelfandDHSninskyJJWhiteTJ, eds. PCR protocols. San Diego, Calif: Academic Press, 1990: 76–83.
11.
GuerreroIPellicerA. Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutat Res1987; 185: 293–308.
12.
McMahonGHansonLLeeJJWoganGN. Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by anatoxin B1. Proc Natl Acad Sci USA1986; 83: 9418–22.
13.
VriesM Verlaan-DeBogaardMEvan den ElstHvan BoomJHvan der EbAJBosJL. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene1986; 50: 313–20.
14.
GrunewaldKLyonsJFrohlichA. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer1989; 43: 1037–41.
15.
ForresterKAlmogueraCHanKGrizzleWEPeruchoM. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature1987; 327: 298–303.
16.
FeigLABastRCKnappRCCooperGM. Somatic activation of ras-K gene in a human ovarian carcinoma. Science1984; 223: 698–701.
17.
RodenhuisSSlebosRJCBootAJM. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res1988; 48: 5738–41.
18.
TsudaHHirohashiSShimosatoYInoYYoshidaTTeradaM. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res1989; 80: 196–9.
19.
FarrCJSaikiRKErlichHAMcCormickFMarshallCJ. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA1988; 85: 1629–33.
